We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Positive Fecal Occult Blood Test Associated with Diabetes

By LabMedica International staff writers
Posted on 25 Jan 2017
Print article
Image: The M40 automatic chemistry analyzer for HbA1c (Photo courtesy of Hitachi).
Image: The M40 automatic chemistry analyzer for HbA1c (Photo courtesy of Hitachi).
Numerous etiologies are implicated in the complications of diabetes and a link between diabetes and the predisposition to certain cancers, including colon cancer, has been established during the last decade.

The fecal occult blood test (FOBT) is a screening method used principally for detection of colon cancer or polyps; however, the relationship between FOBT and diabetes has not been explored in detail, and therefore the association between FOBT result and glycemic status, has been assessed.

Scientists at the Kanagawa University of Human Services have carried out a cross-sectional study and enrolled 12,836 apparently healthy subjects (9,258 men and 3,578 women), aged 30 to 79 years who underwent a medical health checkup at the Saitama Health Promotion Corporation in 2012. Anthropometric and laboratory tests were carried out after overnight fasting.

Serum parameters were measured using standard methods on Hitachi autoanalyzers. All subjects were classified according to their glycated hemoglobin (HbA1c) into normal (HbA1c equal to or less than 5.69%), prediabetic (HbA1c 5.7% to 6.49%) and diabetic (HbA1c equal to or greater than 6.5%) groups, regardless of whether they were being treated for diabetes. FOBT was performed automatically using a diagnostic test kit the magnetic particle agglutination method, for the detection of human hemoglobin in fecal samples. A positive FOBT was defined according to the two-day stool sampling method.

The team found that mean age and HbA1c were significantly higher in the 1,502 in the positive group than the 11,334 in negative FOBT groups. There were fewer men and current smokers in the positive FOBT group. Multivariate logistic regression analysis showed that, compared with HbA1c of less than 5.69%, HbA1c of greater than 6.5% was significantly associated with positive FOBT, independently of relevant confounders including age, sex, and past history of gastric/duodenal ulcers and colon cancer or polyp.

The authors concluded that their results indicate a significant association between diabetes and positive FOBT in a Japanese population undergoing general health screening. This supports the position that subjects with diabetes may be predisposed towards gastrointestinal cancer or may suggest the presence of microangiopathy in the gut. The study was published in the January 2017 issue of the journal Clinical Biochemistry.

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.